Paul Anthony Brennan - Net Worth and Insider Trading
Paul Anthony Brennan Net Worth
The estimated net worth of Paul Anthony Brennan is at least $88,800 dollars as of 2024-11-13. Paul Anthony Brennan is the Senior Officer of Eupraxia Pharmaceuticals Inc and owns about 22,200 shares of Eupraxia Pharmaceuticals Inc (TSX:EPRX) stock worth over $88,800. Details can be seen in Paul Anthony Brennan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul Anthony Brennan has not made any transactions after 2023-03-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Paul Anthony Brennan
Paul Anthony Brennan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Paul Anthony Brennan owns 1 companies in total, including Eupraxia Pharmaceuticals Inc (TSX:EPRX) .
Click here to see the complete history of Paul Anthony Brennan’s form 4 insider trades.
Insider Ownership Summary of Paul Anthony Brennan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:EPRX | Eupraxia Pharmaceuticals Inc | 2023-03-30 | Senior Officer |
Paul Anthony Brennan Latest Holdings Summary
Paul Anthony Brennan currently owns a total of 1 stock. Paul Anthony Brennan owns 22,200 shares of Eupraxia Pharmaceuticals Inc (TSX:EPRX) as of March 30, 2023, with a value of $88,800.
Latest Holdings of Paul Anthony Brennan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:EPRX | Eupraxia Pharmaceuticals Inc | 2023-03-30 | 22,200 | 4.00 | 88,800 |
Holding Weightings of Paul Anthony Brennan
Paul Anthony Brennan Form 4 Trading Tracker
According to the SEC Form 4 filings, Paul Anthony Brennan has made a total of 2 transactions in Eupraxia Pharmaceuticals Inc (TSX:EPRX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Eupraxia Pharmaceuticals Inc is the acquisition of 900 shares on March 30, 2023, which cost Paul Anthony Brennan around $3,725.
Insider Trading History of Paul Anthony Brennan
- 1
Paul Anthony Brennan Trading Performance
GuruFocus tracks the stock performance after each of Paul Anthony Brennan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul Anthony Brennan is 104.34%. GuruFocus also compares Paul Anthony Brennan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul Anthony Brennan within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Paul Anthony Brennan's insider trading performs compared to the benchmark.
Performance of Paul Anthony Brennan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 45.46 | | | | | |
| Relative Return to S&P 500(%) | 42.24 | | | | | |
Paul Anthony Brennan Ownership Network
Ownership Network List of Paul Anthony Brennan
Ownership Network Relation of Paul Anthony Brennan
Paul Anthony Brennan Owned Company Details
What does Eupraxia Pharmaceuticals Inc do?
Who are the key executives at Eupraxia Pharmaceuticals Inc?
Paul Anthony Brennan is the Senior Officer of Eupraxia Pharmaceuticals Inc. Other key executives at Eupraxia Pharmaceuticals Inc include Senior Officer Amanda Michelle Malone , Director or Senior Officer of 10% Security Holder James Besser , and Director or Senior Officer of 10% Security Holder Morgan Frank .
Eupraxia Pharmaceuticals Inc (TSX:EPRX) Insider Trades Summary
Over the past 18 months, Paul Anthony Brennan made no insider transaction in Eupraxia Pharmaceuticals Inc (TSX:EPRX). Other recent insider transactions involving Eupraxia Pharmaceuticals Inc (TSX:EPRX) include a net purchase of 3,800 shares made by Michael Wilmink ,
In summary, during the past 3 months, insiders sold 0 shares of Eupraxia Pharmaceuticals Inc (TSX:EPRX) in total and bought 1,900 shares, with a net purchase of 1,900 shares. During the past 18 months, 0 shares of Eupraxia Pharmaceuticals Inc (TSX:EPRX) were sold and 3,800 shares were bought by its insiders, resulting in a net purchase of 3,800 shares.
Eupraxia Pharmaceuticals Inc (TSX:EPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eupraxia Pharmaceuticals Inc Insider Transactions
Paul Anthony Brennan Mailing Address
Above is the net worth, insider trading, and ownership report for Paul Anthony Brennan. Currently GuruFocus does not have mailing address information for Paul Anthony Brennan.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
